Sponsor Pipeline

Taiho Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
2
Phase 3
10
Disease Areas
9
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-11 NCT04608110
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome		 Primary endpoint(s) modified
2026-08-11 NCT04608110
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome		 Enrollment increased: 40 -> 59 participants
2026-08-11 NCT04608110
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome		 Trial arms changed: 1 -> 3
2026-08-11 NCT04608110
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome		 date change Primary completion pushed: 2025-12 -> 2027-12
2026-08-11 NCT04608110
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome		 date change Completion pushed: 2026-01 -> 2028-01
2026-08-06 NCT04999761
AB122 Platform Study		 Primary endpoint(s) modified
2026-08-06 NCT04999761
AB122 Platform Study		 Trial arms changed: 17 -> 18
2026-08-06 NCT04999761
AB122 Platform Study		 date change Primary completion pushed: 2026-05 -> 2027-06
2026-08-06 NCT04999761
AB122 Platform Study		 date change Completion pushed: 2026-05 -> 2027-06
Active Trials by Phase
Phase 3
2
Phase 1/2
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07710885 Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer Biliary Tract Cancer Recruiting
NCT04587908 A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） Duchenne Muscular Dystrophy Active, Not Recruiting
Phase 1/2
NCT04683250 Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene… RET-altered Non Small Cell Lung Cancer Recruiting
Phase 1
NCT04999761 AB122 Platform Study Advanced or Metastatic Solid Tumor Recruiting
NCT04608110 A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome Myelodysplastic Syndrome (MDS) Recruiting
NCT05245968 A Study of Pimitespib in Combination With Imatinib in Patients With GIST… Gastrointestinal Stromal Tumors Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Cholangiocarcinoma (2) Duchenne Muscular Dystrophy (1) Myelodysplastic Syndromes (MDS) (1) Colorectal Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Head & Neck Cancer (1) Esophageal Cancer (1)
Get alerts when Taiho Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free